Table 2. Comparison of laboratory results of preeclampsia and control groups.
Comparasion | Preeclampsia Group (n=66) Mean± SD Median (Min-Max) | Control Group (n=68) Mean ± SD Median (Min-Max) | p-value |
---|---|---|---|
Hemoglobin (g/dl) | 12.1±1.5 11.9 (8.3-15.3) | 11.9±3.1 11.7 (8.5-13.9) | 0.093 |
Hematocrit (%) | 36.8±4.1 36.3 (26.1-49.4) | 34.8±4.5 34.9 (11.5-41.4) | 0.036* |
Leukocyte (/mm3) | 10976.5±2710.4 10680 (5380-20900) | 10831.3±3220.4 10430 (5790-23320) | 0.445 |
Platelet (/mm3) | 238197±73836 243500(64000-457000) | 233485.3±71958.6 225000(128000-423000) | 0.476 |
Fibrinogen (mg/dl) | 503.4±95.6 515.0 (265-763) | 504.3±86.5 504.5 (276-708) | 0.956 |
Creatinine (mg/dl) | 0.6±0.1 0.5 (0.3-1.1) | 0.4±0.1 0.4 (0.3-0.6) | <0.001* |
Uric Acid (mg/dl) | 5.2±1.4 5.4 (2.7-10.0) | 3.5±1.2 3.2 (1.6-7.0) | <0.001* |
Spot urine protein/Creatinine | 1.0±1.2 0.6 (0.1-6.1) | 0.1±0.1 0.1 (0.1-0.2) | <0.001* |
24 Hour urine protein (mg) | 978.4±1198.9 462 (129-60002) | 241.5±55.9 241.5 (202-281) | 0.002* |
Na (mEq/L) | 135.7±2.1 136 (131-140) | 136.9±1.8 137 (133-141) | 0.002* |
AST (U/L) | 21.4 ±19.2 16 (10-155) | 15.6±5.6 14.0 (6-38) | 0.002* |
ALT (U/L) | 18.5±32.8 11.5 (4-263) | 10.3±5.8 8 (1-32) | 0.008* |
LDH (U/L) | 248.3±83.6 223 (147-559) | 189.3±30.2 192 (127-268) | <0.001* |
INR | 1.0±0.1 1.0 (0.9-1.5) | 1.01±0.1 1.0 (0.9-1.2) | 0.003* |
IMA (ABSU) | 1.02±0.15 1.02 (0.66-1.44) | 0.93±0.10 0.94 (0.66-1.16) | <0.001* |
Na – Sodium; AST - aspartate aminotransferase; ALT - alanine aminotransferase; LDH - lactate dehydrogenase; INR - international normalized ratio; IMA - ischemia modified albümin; *Statistically significant at p < 0.05 (Laboratory results at the time of admission)